Screening of FDA-approved compound library identifies potential small-molecule inhibitors of SARS-CoV-2 non-structural proteins NSP1, NSP4, NSP6 and NSP13: molecular modeling and molecular dynamics studies | SpringerLink
Frontiers | Virtual screening and drug repositioning of FDA-approved drugs from the ZINC database to identify the potential hTERT inhibitors
Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2 - Journal of Pharmaceutical Sciences
Frontiers | Virtual screening and drug repositioning of FDA-approved drugs from the ZINC database to identify the potential hTERT inhibitors
Frontiers | Virtual screening and drug repositioning of FDA-approved drugs from the ZINC database to identify the potential hTERT inhibitors
PDF) Virtual Screening of an FDA Approved Drugs Database on Two COVID-19 Coronavirus Proteins
ZINC Catalog FDA-approved drugs (via DSSTOX) | ZINC Is Not Commercial - A database of commercially-available compounds
Screening of FDA-approved compound library identifies potential small-molecule inhibitors of SARS-CoV-2 non-structural proteins NSP1, NSP4, NSP6 and NSP13: molecular modeling and molecular dynamics studies | SpringerLink
Screening of FDA-approved compound library identifies potential small-molecule inhibitors of SARS-CoV-2 non-structural proteins NSP1, NSP4, NSP6 and NSP13: molecular modeling and molecular dynamics studies | SpringerLink
ZINC Catalog FDA-approved drugs (via DSSTOX) | ZINC Is Not Commercial - A database of commercially-available compounds
Frontiers | Virtual screening and drug repositioning of FDA-approved drugs from the ZINC database to identify the potential hTERT inhibitors
ZINC Catalog FDA-approved drugs (via DSSTOX) | ZINC Is Not Commercial - A database of commercially-available compounds
Screening of FDA-approved compound library identifies potential small-molecule inhibitors of SARS-CoV-2 non-structural proteins NSP1, NSP4, NSP6 and NSP13: molecular modeling and molecular dynamics studies | SpringerLink
PDF) A dynamic simulation study of FDA drug from zinc database against COVID-19 main protease receptor
PDF) A dynamic simulation study of FDA drug from zinc database against COVID-19 main protease receptor
Frontiers | Virtual screening and drug repositioning of FDA-approved drugs from the ZINC database to identify the potential hTERT inhibitors
Virtual Screening of an FDA Approved Drugs Database on Two COVID-19 Coronavirus Proteins | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage
Compound database
How can I download FDA approved drugs from zinc database ? | ResearchGate
How to download small molecules from ZINC database for virtual screening? — Bioinformatics Review
PDF) A dynamic simulation study of FDA drug from zinc database against COVID-19 main protease receptor
Screening of FDA-approved compound library identifies potential small-molecule inhibitors of SARS-CoV-2 non-structural proteins NSP1, NSP4, NSP6 and NSP13: molecular modeling and molecular dynamics studies | SpringerLink
Frontiers | Virtual screening and drug repositioning of FDA-approved drugs from the ZINC database to identify the potential hTERT inhibitors
PDF) A dynamic simulation study of FDA drug from zinc database against COVID-19 main protease receptor
